Shopping Cart
- Remove All
- Your shopping cart is currently empty
RIPK1-IN-19 is a selective and potent bimodal RIPK1 inhibitor with IC50=15 nM that protects against cell necrosis and works well in the tnf α-induced Systemic Inflammatory Response Syndrome (SIRS) model and imiquimod (IMQ)-induced psoriasis model.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $71 | In Stock | |
5 mg | $172 | In Stock | |
10 mg | $277 | In Stock | |
25 mg | $556 | In Stock | |
50 mg | $887 | In Stock | |
100 mg | $1,390 | In Stock | |
200 mg | $1,890 | In Stock |
Description | RIPK1-IN-19 is a selective and potent bimodal RIPK1 inhibitor with IC50=15 nM that protects against cell necrosis and works well in the tnf α-induced Systemic Inflammatory Response Syndrome (SIRS) model and imiquimod (IMQ)-induced psoriasis model. |
Targets&IC50 | RIPK1:15 nM |
Molecular Weight | 496.54 |
Formula | C28H25FN6O2 |
Cas No. | 2763831-43-0 |
Smiles | C(N[C@@H](C)C1=CC(F)=CC=C1)(=O)C=2C=3C(N(C)C2)=CC=C(C3)C4=CC=5N(C=C4)N=C(NC(=O)C6CC6)N5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.